In a 2008 annual report to it’s shareholders and investors, Chugai Pharmaceutical Co., LTD, predicted that sales of Tamiflu would increase by 531% in 2009. As you most likely already know, the media has been promoting Tamiflu as the number one medicine to combat the so-called Swine Flu.
According to Chugai Pharmaceutical’s annual report, found here, the reason for this spike in sales would be due to “expected resumption of government stockpiling … and the ongoing recovery of the prescription rate for seasonal influenza.”
Chugai Pharmaceutical is a major Japanese drug manufacturer, with 51.5% of it’s shares owned by Hoffman-La Roche.
